The Bharathidasan University and Mediscan Institute of Medical Education, Chennai invite applications for admission to their job-oriented full-time, two year, diploma programmes.
Canada has offered its partnership in areas like agriculture, mining, life sciences, ICT, financial services and infrastructure. Canada's aim in India was to create new Canadian connections in sectors like agriculture, mining, life sciences, information and communication technology (ICT), financial services and infrastructure, areas where that country's firms have proven expertise. Canadian rep hoped to see Canadian companies becoming active in the Indian market & vice versa.
The west is faced with a daunting task on patent expiry, increasing challenges from generics, pipeline showing limited blockbusters, and in addition to that increasing pricing pressure.
Ranbaxy board has approved the hive off of its R&D unit, with an 1:4 share swap ratio.
The strike affected attendance in government offices and banks, the officials said.
Had he not taken his final curtain call on April 23, 1992, Satyajit Ray would still, undoubtedly, have been making movies.
Signs of alien life will be detected by 2025, while "definitive evidence" of extra-terrestrial beings may be found within the next 20 to 30 years, top NASA scientists say.
The Institute of Clinical Research (India) invites applications for its one-year part-time Professional Certificate Programme in Clinical Research and Trials Management and the Professional Certificate Programme in Regulatory Affairs and Ethics.
It's addictive. It's entertaining. It's gorgeous. Once bitten by the K-drama bug, there's no going back.
The Welingkar Institute of Management, India, and Nottingham Trent University, UK, invite applications for their M Sc Bioinformatics programme.
All work in the armed forces is team work. One has to deal with people all the time -- at work, play and even during war, advises IAF Veteran Air Commodore Nitin Sathe.
Biovel Life Sciences (P) Ltd, a biotechnology firm, has inked a licensing agreement with US-based Dowpharma to produce Human Growth Hormone using Pfenex Expression Technology, for the first time globally.
According to various global media reports, China is creating Covid-like pathogens in Pakistan that have the potential of causing virus contamination on a scale far higher than Covid.
The primary market is set for a bumper Rs 80,000-crore bonanza with 30 companies already filing IPO papers to raise Rs 55,000 crore, while around 10 more are lined up for this month itself, seeking to mop up another Rs 25,000 crore, say investment bankers. The market has been on a non-stop rally, hitting new records almost every week, on the back of an influx of investors -- a vast majority of them first-timers -- coupled with a flood of liquidity. Foreign funds alone had pumped in a record $35 billion into the market in FY21, while the trend has continued this fiscal as well. Domestic institutions led by LIC have also infused trillions of rupees, helping woo retail investors in troves -- the year saw over 20 million new investors coming to the market.
Hiring for management professionals with greater than 16 years of experience witnessed a spike of 66% compared to last year.
Reliance Pharmaceuticals, the proposed pharmaceutical manufacturing company promoted by Mukesh Ambani's Reliance Life Sciences, will soon rope in a consultant to give final shape to the project, slated to take off within two years.
'There is a conscious move by the BJP to distance itself from the current state leadership.'
Corporate India handed over an average increment of 8 per cent in 2021, and early estimates reveal that average increment for 2022 is expected to increase to 8.6 per cent in line with a healing economy and improving confidence, according to a Deloitte survey. As per the second phase of Deloitte's Workforce and Increment Trends survey 2021, 92 per cent companies gave an increment in 2021 at an average of 8 per cent, compared with only 4.4 per cent in 2020, where just 60 per cent companies had extended a pay hike. For 2022, average increment is expected to increase to 8.6 per cent, at par with the pre-pandemic levels of 2019, the survey said, adding that about 25 per cent companies surveyed have projected a double-digit increment for 2022.
Competing with established biotech companies in India such as Wockhardt, Biocon and Reliance Life Sciences, small biotech companies such as Zenotech, BV Biocorp and Intas Biopharma are likely to emerge as major players in biogeneric drugs.
S Bhaskaran is the first bodybuilder to be presented the Arjuna Award in 20 years.
Global pharma and biotech companies, especially those from US, Europe and Japan, are keen to sign agreements with Indian companies, according to experts.
Crime, climate change and cool Oscar winners dominate the OTT menu this week.
Despite news of the private equity in the domestic healthcare and pharma industry touching almost Rs 40 crore (Rs 40 million) in the first nine months of the year, PE firms are not exactly bullish about investing in the pharma industry alone. In fact, a closer look at the investments reveals that a larger part of the money is being flown into healthcare delivery systems like hospital chains and not in pharma companies.
The Delhi police had earlier said it arrested two 'suspicious' men and recovered two hand grenades from their house in the Bhalswa Dairy area of Jahangirpuri.
'Essentially there are three things the government should be doing: Identify who you are going to get your vaccine from, figure out how you are going to pay for it, and figure out how you're going to deliver it and to whom.'
Chandrayaan 3 follows the Chandrayaan 2 mission which did not achieve the desired soft landing on the surface of the moon in 2019, disappointing the scientists.
Suven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research for central nervous system disorder.
More than 70 per cent of Indian youth aged between 15 and 29 can't!
Software services firm Netkraft on Thursday said it is being acquired by the privately held business process and technology consulting company, the United States-based Adea Solutions, in an all-cash deal.
The deluge of offerings in the primary market, a muted results season and increasing talks of a Fed taper may quicken the pace of overseas investors selling Indian equities in the near term. The next few weeks may see a dozen companies tap the market for initial public offerings and raise about Rs 30,000 crore. These include the likes of Zomato, Glenmark Life Sciences, Utkarsh Small Finance Bank and Seven Islands Shipping.
Hyderabad is fast emerging as destination for pharma and bio-tech industries with projected growth of 30 to 40 per cent, consultant company Frost and Sullivan has said.
A seasonally-strong quarter, with no immediate impact of the second wave and continued acceleration of digital transformation will allow the IT services sector to report a robust Q1 this financial year. However, key metrics to look out for will be attrition rate and margin lever as they will be impacted by salary hikes. Analysts expect growth for the quarter to be broad-based, with sectors like banking, financial services and insurance (BFSI), retail, manufacturing, hi-tech and life sciences driving revenue growth. Analysts across brokerage houses are pegging revenue growth in the range of 1.5 per cent to 4.5 per cent.
India, with its strong research and development base in life sciences, IT and pharma industries, is on the threshold of a revolution in biotechnology, scientists at the BioAsia 2004 Summit said in Hyderabad on Thursday.
Indian companies are likely to shell out an average salary increment of 10.3 per cent in the current fiscal with employees in pharma, health care and life sciences projected to get 12.4 per cent raise, says a survey.
Wipro's clients currently include over 100 US payers, healthcare providers, and public health agencies.
Emphasising that various issues are on agenda at the G20 under India's leadership.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances